510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1528-2015Class II

MicroScan Microbiology Systems: Dried Gram Negative MIC/Combo Panels Containing Lower Imipenem Dilutions for...

Siemens Healthcare Diagnostics Inc. / initiated 2014-08-08 / Terminated / root cause: labeling and UDI

Beckman Coulter, Inc. began a recall of MicroScan Microbiology Systems: Dried Gram Negative MIC/Combo Panels Containing Lower Imipenem Dilutions for Reporting CLSI M100-S20 Breakpoints Panel: Neg... on . FDA classified it as Class II and gives the reason as "Technical Support Bulletin issued in February 2013 did not mention performance limitation for Proteus mirabilis and Imp when using the CLSIM100-S20 revised interpretive criteria". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1528-2015
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
MicroScan Microbiology Systems: Dried Gram Negative MIC/Combo Panels Containing Lower Imipenem Dilutions for Reporting CLSI M100-S20 Breakpoints Panel: Neg Combo 50, Catalog B1017-406 Microbiology: For use with MicroScan Dried Gram Negative MIC/Combo Panels and Dried Gram Negative Breakpoint Combo Panels. MicroScan panels are designed for use in determining antimicrobial agent susceptibility and/or identification to the species level of aerobic and facultatively anaerobic gram-negative bacilli.
Product code
JWY Manual Antimicrobial Susceptibility Test Systems
Reason for recall
Technical Support Bulletin issued in February 2013 did not mention performance limitation for Proteus mirabilis and Imp when using the CLSIM100-S20 revised interpretive criteria.
Root cause tag
labeling and UDI
FDA root cause
Labeling False and Misleading
Action
The firm, Siemens, sent an "Urgent Medical Device Correction" letter dated August 7, 2014 to affected customers by trackable method. The letter describe product, problem and actions to be taken. The customers were instructed to confirm receipt of the letter; complete the attached "Field Correction Effectiveness Check" form via fax to Siemens Healthcare Diagnostics at 302-631-8467;TSB 190 has been removed from use and archived from the Siemens Document Library, if you have a hardcopy, discard it appropriately;and follow the listed in instructions and retain and forward this letter to those who may have received this product. If you have any questions, please contact your Siemens Customer Care Center; Quality Systems & Compliance Director at 916-374-3031 or email: [email protected] or your local Siemens technical support representative.
Quantity in commerce
Approx ~(216240 boxes U.S. and 84249 boxes OUS) total
Distribution
Worldwide Distribution: US (Nationwide) and to countries of: Argentina, Bahamas, Brazil, Canada, China, Ecuador, Egypt, Germany, Lithuania, Mexico, Paraguay, Peru Poland, Portugal, Romania, Russian Federation, Singapore, South Africa, Spain, Taiwan, Thailand, Trinidad and Tobago, United Arab Emirates, Uruguay, and Venezuela.
Product codes and lots
Catalog number: B1017-406; Siemens Material Number (SMN): 10444700.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1528-2015
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1528-2015Class IITerminatedVoluntary: Firm initiated
Z-1529-2015Class IITerminatedVoluntary: Firm initiated
Z-1530-2015Class IITerminatedVoluntary: Firm initiated
Z-1531-2015Class IITerminatedVoluntary: Firm initiated
Z-1532-2015Class IITerminatedVoluntary: Firm initiated
Z-1533-2015Class IITerminatedVoluntary: Firm initiated
Z-1534-2015Class IITerminatedVoluntary: Firm initiated